SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Immunomedics (IMMU) - moderated
An SI Board Since September 2006
Posts SubjectMarks Bans Symbol
63393 356 15 IMMU
Emcee:  idahoranch1 Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
60982Very bad news for SAVA. Between this and CTMX, I'm taking a shellacking thisdrtom1234-7/27/2022
60981Probably trying to get AUPH to settle out of court. "How­ev­er, chandler27-7/27/2022
60980AT THE PTAB BLOG 10-Year Anniversary of the AIA at the PTAB?Not Your Grandparendorightbythem-7/26/2022
60979Sun pharmaceuticals sells generics. I would speculate that if they would like toOlecranon17/26/2022
60978Stupid question for ya: Why is SUN challenging this? What do they in particulaplhky3465-7/26/2022
60977Surprised, no comment on Auph v. Sun patent dispute. Have to wait until July, 20dorightbythem-7/26/2022
60976"...resulting in me being lucky..." Hey, it worked once! If you can jerickerickson-7/25/2022
60975I was not a fan of the Goldenbergs and I have not been impressed with Barbier, ejargonweary17/25/2022
60974another AD article that casually refers to Simufilam, although with a glaring erscorman137/25/2022
60973I take some comfort in SAVA's financials in the midst of all the FUD. On a verickerickson27/24/2022
60972Yep. All true. And yet if Simufilam’s efficacy and safety are confirmed in the jargonweary-7/24/2022
60971Thanks, jw. Despite, the fact that the allegations appear to be mere handwaving,Olecranon27/24/2022
60970Yes, this article contains no new information or allegations regarding SAVA. Thjargonweary67/22/2022
60969Same old images, more or less the same old debate, but a new investigator, and pOlecranon-7/22/2022
60968Some good news for AUPH regarding European approval. Now please, management, jusdrtom123447/22/2022
60967I increased my # of CBAY shares by 33% when CBAY was selling for $1.84 in the ovOlecranon27/21/2022
60966And of course, as soon as I extol the virtues of CBAY, it immediately drops overdrtom1234-7/21/2022
60965All very reasonable. Personally, I think the last 17 months have been a historicdrtom123477/19/2022
60964drtom1234, had another poster ask about CBAY via private message, so I respondeallatwwk17/18/2022
60963I'm surprised you chose to exit CBAY in particular. From a fundamentals standrtom123417/18/2022
60962As I see it, Phase III will validate whether or not SavaDx confirms the MoA of Sghettogoulash-7/18/2022
60961 << I have no idea what FDA regulations are for approval of a patented diaghettogoulash17/18/2022
60960Yeah, that makes sense. While other competitors are developing blood based diagnghettogoulash-7/16/2022
60959I have said this before. The company's 180° flip-flopping on SavaDx-- tghettogoulash-7/16/2022
60958Updates on my biopharma holdings Decided to exit CBAY, MRNS and MRSN. Losses wallatwwk47/15/2022
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News